KPC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares KPC Pharmaceuticals Inc with three other
companies in this sector in China:
Guizhou Xinbang Pharmaceutical Company Limited
sales of 6.00 billion Chinese Renmimbi [US$887.05 million]
of which 63%
was Pharmaceutical industry),
FUREN Group Pharmaceutical Co Ltd
(5.80 billion Chinese Renmimbi [US$857.11 million]
of which 85%
was Pharmaceutical Industry), and
Zhejiang Medicine Co., Ltd.
(5.69 billion Chinese Renmimbi [US$841.25 million]
of which 43%
was Life Nourishment).
KPC Pharmaceuticals Inc reported sales of 5.85 billion Chinese Renmimbi (US$864.85 million)
December of 2017.
increase of 14.7%
versus 2016, when the company's sales were 5.10 billion Chinese Renmimbi.
Sales at KPC Pharmaceuticals Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 94%).
Sales of Daily Necessities saw an increase
that was more than double the company's growth rate: sales were up
351.2% in 2017, from
956,636.43 Chinese Renmimbi to 4.32 million Chinese Renmimbi.
KPC Pharmaceuticals Inc also saw significant increases in sales in
Oral Agents (up 23.4% to 1.83 billion Chinese Renmimbi)
Injection (up 30.0% to 1.35 billion Chinese Renmimbi)
Medical Services (up 343.3% to 2.88 million Chinese Renmimbi)
Other (up 110.9% to 93.08 million Chinese Renmimbi)
Not all segments of KPC Pharmaceuticals Inc experienced an increase in sales in 2017:
sales of Other Operating fell 46.3% to 61.83 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).